Development of a novel scoring system for glaucoma risk based on demographic and laboratory factors using ChatGPT-4.

IF 2.6 4区 医学 Q2 COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS Medical & Biological Engineering & Computing Pub Date : 2025-01-01 Epub Date: 2024-08-12 DOI:10.1007/s11517-024-03182-0
Joon Yul Choi, Tae Keun Yoo
{"title":"Development of a novel scoring system for glaucoma risk based on demographic and laboratory factors using ChatGPT-4.","authors":"Joon Yul Choi, Tae Keun Yoo","doi":"10.1007/s11517-024-03182-0","DOIUrl":null,"url":null,"abstract":"<p><p>We developed a scoring system for assessing glaucoma risk using demographic and laboratory factors by employing a no-code approach (automated coding) using ChatGPT-4. Comprehensive health checkup data were collected from the Korea National Health and Nutrition Examination Survey. Using ChatGPT-4, logistic regression was conducted to predict glaucoma without coding or manual numerical processes, and the scoring system was developed based on the odds ratios (ORs). ChatGPT-4 also facilitated the no-code creation of an easy-to-use risk calculator for glaucoma. The ORs for the high-risk groups were calculated to measure performance. ChatGPT-4 automatically developed a scoring system based on demographic and laboratory factors, and successfully implemented a risk calculator tool. The predictive ability of the scoring system was comparable to that of traditional machine learning approaches. For high-risk groups with 1-2, 3-4, and 5 + points, the calculated ORs for glaucoma were 1.87, 2.72, and 15.36 in the validation set, respectively, compared with the group with 0 or fewer points. This study presented a novel no-code approach for developing a glaucoma risk assessment tool using ChatGPT-4, highlighting its potential for democratizing advanced predictive analytics, making them readily available for clinical use in glaucoma detection.</p>","PeriodicalId":49840,"journal":{"name":"Medical & Biological Engineering & Computing","volume":" ","pages":"75-87"},"PeriodicalIF":2.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical & Biological Engineering & Computing","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s11517-024-03182-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS","Score":null,"Total":0}
引用次数: 0

Abstract

We developed a scoring system for assessing glaucoma risk using demographic and laboratory factors by employing a no-code approach (automated coding) using ChatGPT-4. Comprehensive health checkup data were collected from the Korea National Health and Nutrition Examination Survey. Using ChatGPT-4, logistic regression was conducted to predict glaucoma without coding or manual numerical processes, and the scoring system was developed based on the odds ratios (ORs). ChatGPT-4 also facilitated the no-code creation of an easy-to-use risk calculator for glaucoma. The ORs for the high-risk groups were calculated to measure performance. ChatGPT-4 automatically developed a scoring system based on demographic and laboratory factors, and successfully implemented a risk calculator tool. The predictive ability of the scoring system was comparable to that of traditional machine learning approaches. For high-risk groups with 1-2, 3-4, and 5 + points, the calculated ORs for glaucoma were 1.87, 2.72, and 15.36 in the validation set, respectively, compared with the group with 0 or fewer points. This study presented a novel no-code approach for developing a glaucoma risk assessment tool using ChatGPT-4, highlighting its potential for democratizing advanced predictive analytics, making them readily available for clinical use in glaucoma detection.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用 ChatGPT-4 开发基于人口和实验室因素的新型青光眼风险评分系统。
我们利用 ChatGPT-4 采用无代码方法(自动编码),开发了一套利用人口统计学和实验室因素评估青光眼风险的评分系统。我们从韩国国民健康与营养调查中收集了全面的健康检查数据。使用 ChatGPT-4 进行逻辑回归预测青光眼,无需编码或手动数字处理,并根据几率比(ORs)建立了评分系统。此外,ChatGPT-4 还有助于创建一个无需编码、易于使用的青光眼风险计算器。通过计算高危人群的几率比来衡量绩效。ChatGPT-4 根据人口统计学和实验室因素自动开发了一个评分系统,并成功实施了风险计算器工具。该评分系统的预测能力与传统的机器学习方法相当。在验证集中,对于 1-2、3-4 和 5 + 分的高风险组,与 0 分或更低分的组相比,青光眼的计算 OR 分别为 1.87、2.72 和 15.36。本研究提出了一种利用 ChatGPT-4 开发青光眼风险评估工具的新颖无代码方法,突出了其将高级预测分析民主化的潜力,使其可随时用于青光眼的临床检测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical & Biological Engineering & Computing
Medical & Biological Engineering & Computing 医学-工程:生物医学
CiteScore
6.00
自引率
3.10%
发文量
249
审稿时长
3.5 months
期刊介绍: Founded in 1963, Medical & Biological Engineering & Computing (MBEC) continues to serve the biomedical engineering community, covering the entire spectrum of biomedical and clinical engineering. The journal presents exciting and vital experimental and theoretical developments in biomedical science and technology, and reports on advances in computer-based methodologies in these multidisciplinary subjects. The journal also incorporates new and evolving technologies including cellular engineering and molecular imaging. MBEC publishes original research articles as well as reviews and technical notes. Its Rapid Communications category focuses on material of immediate value to the readership, while the Controversies section provides a forum to exchange views on selected issues, stimulating a vigorous and informed debate in this exciting and high profile field. MBEC is an official journal of the International Federation of Medical and Biological Engineering (IFMBE).
期刊最新文献
LGENet: disentangle anatomy and pathology features for late gadolinium enhancement image segmentation. M4S-Net: a motion-enhanced shape-aware semi-supervised network for echocardiography sequence segmentation. Deep learning for retinal vessel segmentation: a systematic review of techniques and applications. TongueTransUNet: toward effective tongue contour segmentation using well-managed dataset. Drug repositioning based on mutual information for the treatment of Alzheimer's disease patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1